Outcomes in patients with metastatic gastric cancer: a surveillance, epidemiology, and end results program (SEER) database analysis

References

• Asakura H, Hashimoto T, Harada H, Mizumoto M, Furutani K, Hasuike N, Matsuoka M, Ono H, Boku N, Nishimura T. 2011. Palliative radiotherapy for bleeding from advanced gastric cancer: is a schedule of 30 Gy in 10 fractions adequate? J Cancer Res Clin Oncol. 137(1):125–130. doi:10.1007/s00432-010-0866-z.
   PubMed Web of Science ®Google Scholar
• Bando E, Ji X, Kattan MW, Seo HS, Song KY, Park CH, Bencivenga M, de Manzoni G, Terashima M. 2020. Development and validation of a pretreatment nomogram to predict overall survival in gastric cancer. Cancer medicine.
   Google Scholar
• Bilici A. 2014. Treatment options in patients with metastatic gastric cancer: current status and future perspectives. World J Gastroenterol. 20(14):3905–3915. doi:10.3748/wjg.v20.i14.3905.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Laversanne M, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, Steliarova-Foucher E, Swaminathan R, Antoni S, et al. 2015. CancerIncidence inFiveContinents: Inclusion criteria, highlights from Volume X and the global status of cancer registration. Int J Cancer. 137(9):2060–2071. doi:10.1002/ijc.29670.
   PubMed Web of Science ®Google Scholar
• Chen L, Song MQ, Lin HZ, Hao LH, Jiang XJ, Li ZY, Chen YX. 2013. Chemotherapy and resection for gastric cancer with synchronous liver metastases. World J Gastroenterol. 19(13):2097–2103. doi:10.3748/wjg.v19.i13.2097.
   PubMed Web of Science ®Google Scholar
• Chen WW, Wang F, Xu RH. 2013. Platinum-based versus non-platinum-based chemotherapy as first line treatment of inoperable, advanced gastric adenocarcinoma: a meta-analysis. PLoS One. 8(7):e68974.
   PubMed Web of Science ®Google Scholar
• Ebinger SM, Warschkow R, Tarantino I, Schmied BM, Güller U, Schiesser M. 2016. Modest overall survival improvements from 1998 to 2009 in metastatic gastric cancer patients: a population-based SEER analysis. Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 19(3):723-734.
   Google Scholar
• Gadde R, Tamariz L, Hanna M, Avisar E, Livingstone A, Franceschi D, Yakoub D. 2015. Metastatic gastric cancer (MGC) patients: Can we improve survival by metastasectomy? A systematic review and meta-analysis. J Surg Oncol. 112(1):38–45. doi:10.1002/jso.23945.
   PubMed Web of Science ®Google Scholar
• Glimelius B, Ekström K, Hoffman K, Graf W, Sjödén PO, Haglund U, Svensson C, Enander LK, Linné T, Sellström H, et al. 1997. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol. 8(2):163–168. doi:10.1023/A:1008243606668.
   PubMed Web of Science ®Google Scholar
• Gold JS, Jaques DP, Bentrem DJ, Shah MA, Tang LH, Brennan MF, Coit DG. 2007. Outcome of patients with known metastatic gastric cancer undergoing resection with therapeutic intent. Ann Surg Oncol. 14(2):365–372. doi:10.1245/s10434-006-9059-z.
   PubMed Web of Science ®Google Scholar
• Han DS, Suh YS, Kong SH, Lee HJ, Choi Y, Aikou S, Sano T, Park BJ, Kim WH, Yang HK. 2012. Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer. J Clin Oncol. 30(31):3834–3840. doi:10.1200/JCO.2012.41.8343.
   PubMed Web of Science ®Google Scholar
• Hartgrink HH, Putter H, Klein Kranenbarg E, Bonenkamp JJ, van de Velde CJ. 2002. Value of palliative resection in gastric cancer. Br J Surg. 89(11):1438–1443. doi:10.1046/j.1365-2168.2002.02220.x.
   PubMed Web of Science ®Google Scholar
• Hiramoto S, Kikuchi A, Tetsuso H, Yoshioka A, Kohigashi Y, Maeda I. 2018. Efficacy of palliative radiotherapy and chemo-radiotherapy for unresectable gastric cancer demonstrating bleeding and obstruction. Int J Clin Oncol. 23(6):1090–1094. doi:10.1007/s10147-018-1317-0.
   PubMed Web of Science ®Google Scholar
• Iacovelli R, Pietrantonio F, Farcomeni A, Maggi C, Palazzo A, Ricchini F, de Braud F, Di Bartolomeo M. 2014. Chemotherapy or targeted therapy as second-line treatment of advanced gastric cancer. A systematic review and meta-analysis of published studies. PLoS One. 9(9):e108940. doi:10.1371/journal.pone.0108940.
   PubMed Web of Science ®Google Scholar
• Izuishi K, Mori H. 2020. Recent strategies for treating stage IV gastric cancer: roles of palliative gastrectomy, chemotherapy, and radiotherapy. J Gastrointestin Liver Dis. 25(1):87–94. doi:10.15403/jgld.2014.1121.251.rv2.
   Google Scholar
• Kramer AA, Zimmerman JE. 2007. Assessing the calibration of mortality benchmarks in critical care: The Hosmer-Lemeshow test revisited*. Crit Care Med. 35(9):2052–2056. doi:10.1097/01.CCM.0000275267.64078.B0.
   PubMed Web of Science ®Google Scholar
• Liang YX, Deng JY, Guo HH, Ding XW, Wang XN, Wang BG, Zhang L, Liang H. 2013. Characteristics and prognosis of gastric cancer in patients aged ≥ 70 years. World J Gastroenterol. 19(39):6568–6578. doi:10.3748/wjg.v19.i39.6568.
   PubMed Web of Science ®Google Scholar
• Liu J, Chen L. 2011. Current status and progress in gastric cancer with liver metastasis. Chin Med J. 124(3):445–456.
   PubMed Web of Science ®Google Scholar
• Martin RC, Jaques DP, Brennan MF, Karpeh M. 2002. Achieving R0 resection for locally advanced gastric cancer: is It worth the risk of multiorgan resection? J Am Coll Surg. 194(5):568–577. doi:10.1016/S1072-7515(02)01116-X.
   PubMed Web of Science ®Google Scholar
• Mohri Y, Tanaka K, Ohi M, Saigusa S, Yasuda H, Toiyama Y, Araki T, Inoue Y, Kusunoki M. 2014. Identification of prognostic factors and surgical indications for metastatic gastric cancer. BMC Cancer. 14:409. doi:10.1186/1471-2407-14-409.
   PubMed Web of Science ®Google Scholar
• Pyrhönen S, Kuitunen T, Nyandoto P, Kouri M. 1995. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer. 71(3):587–591. doi:10.1038/bjc.1995.114.
   PubMed Web of Science ®Google Scholar
• Saito H, Osaki T, Murakami D, Sakamoto T, Kanaji S, Tatebe S, Tsujitani S, Ikeguchi M. 2006. Effect of age on prognosis in patients with gastric cancer. ANZ J Surg. 76(6):458–461. doi:10.1111/j.1445-2197.2006.03756.x.
   PubMed Web of Science ®Google Scholar
• Song P, Wu L, Jiang B, Liu Z, Cao K, Guan W. 2016. Age-specific effects on the prognosis after surgery for gastric cancer: A SEER population-based analysis. Oncotarget. 7(30):48614–48624. doi:10.18632/oncotarget.9548.
   PubMedGoogle Scholar
• Sun J, Song Y, Wang Z, Chen X, Gao P, Xu Y, Zhou B, Xu H. 2013. Clinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysis. BMC Cancer. 13:577. doi:10.1186/1471-2407-13-577.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71(3):209–249. doi:10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Takashima A, Yamada Y, Nakajima TE, Kato K, Hamaguchi T, Shimada Y. 2009. Standard first-line chemotherapy for metastatic gastric cancer in Japan Has Met the global standard: evidence from recent phase III trials. Gastrointestinal Cancer Research: Gcr. 3(6):239–244.
   PubMedGoogle Scholar
• Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. 2010. The global burden of cancer: priorities for prevention. Carcinogenesis. 31(1):100–110. doi:10.1093/carcin/bgp263.
   PubMed Web of Science ®Google Scholar
• Tiberio GA, Baiocchi GL, Morgagni P, Marrelli D, Marchet A, Cipollari C, Graziosi L, Ministrini S, Vittimberga G, Donini A, et al. 2015. Gastric cancer and synchronous hepatic metastases: is it possible to recognize candidates to R0 resection? Ann Surg Oncol. 22(2):589–596. doi:10.1245/s10434-014-4018-6.
   PubMed Web of Science ®Google Scholar
• Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A, Fleig WE. 2006. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol. 24(18):2903–2909. doi:10.1200/JCO.2005.05.0245.
   PubMed Web of Science ®Google Scholar
• Yagi Y, Seshimo A, Kameoka S. 2000. Prognostic factors in stage IV gastric cancer: univariate and multivariate analyses. Gastric Cancer: Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 3(2):71–80.
   Google Scholar
• Zhu Y, Fang X, Wang L, Zhang T, Yu D. 2020. A predictive nomogram for early death of metastatic gastric cancer: A retrospective study in the SEER database and China. J Cancer. 11(18):5527–5535. doi:10.7150/jca.46563.
   PubMed Web of Science ®Google Scholar